CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...
Phase 3
Taipei, Taiwan and 83 other locations
and clinical activity of FB704A in adult patients with severe asthma. The study comprised a 4-week screening period, a 8-week treatment peri...
Phase 2
Taipei, Taiwan and 6 other locations
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
Taipei, Taiwan and 196 other locations
This clinical trial aims to investigate patients with poorly controlled, moderate to severe eosinophilic asthma. The main questions it aims ...
Phase 2
Taipei, Taiwan
The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations....
Phase 2
Taipei, Taiwan and 124 other locations
placebo-controlled and double-blind study to evaluate the efficacy and safety of FB825 in adult patients with moderate-to-severe allergic asthma...
Phase 2
Taipei, Taiwan and 15 other locations
BID using a dry-powder inhaler at one dose level over a 12-week Treatment period in adult participants with uncontrolled moderate-to-severe asthma...
Phase 2
Taipei, Taiwan and 158 other locations
per actuation manufactured by two different manufacturers using methacholine bronchoprovocation challenge test in patients with stable mild asthma...
Taipei City, Taiwan and 11 other locations
of clinically significant exacerbations in participants with severe asthma with an eosinophilic phenotype. Throughout the study, all partici...
Phase 3
Taipei, Taiwan and 419 other locations
administered via a dry powder inhaler in adults with uncontrolled asthma at risk of exacerbations, receiving medium -to -high dose inhaled c...
Phase 2
Taipei, Taiwan and 218 other locations
Clinical trials
Research sites
Resources
Legal